Article
Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?
The American journal of cardiology - 1 Feb 1999
Vancura V, Hubácek J, Málek I, Gebauerová M, Pitha J, Dorazilová Z, Langová M, Zelízko M, Poledne R
Abstract excerpt
To evaluate the role of angiotensin-converting enzyme (ACE) polymorphism on the development of end-stage dilated cardiomyopathy, the ACE gene polymorphism of 90 patients after heart transplantation because of this disease was compared with the population sample. No difference in gene frequencies was found, but when compared with the population sample there were fewer ID heterozygotes detected; no significant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
